advertisement

HIV/AIDS

13 July 2011

Cheaper drugs for Aids patients

Gilead Sciences Inc. will allow some Aids drugs to be made by generic manufacturers, potentially increasing their availability in poor countries, particularly in Africa.

Gilead Sciences Inc. will allow some of its Aids drugs to be made by generic manufacturers, potentially increasing their availability in poor countries, particularly in Africa, officials said.

The deal was negotiated by the Medicines Patent Pool, part of a UN led partnership that raises money for Aids, tuberculosis and malaria by things like taxing airplane tickets. Among the partnership's 29 member countries, only Chile, France, Korea, Mali and Niger are actually implementing the airline tax.

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.